SLC5A1 and type 2 diabetes mellitus: Acarbose, Phlorizin (a glucoside of phloretin) and other natural α-amylase, α-glucosidase, and SGLT1 inhibitors have been utilized as pharmacological agents or in the treatment of type 2 diabetes [33,34].